Overview

A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected Patients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To explore the antiviral efficacy, tolerability and safety of saquinavir plus zidovudine plus lamivudine.
Phase:
Phase 2
Details
Lead Sponsor:
Hoffmann-La Roche
Treatments:
Lamivudine
Saquinavir
Zidovudine